Biomorphis Limited Filleted Accounts Cover |
Company No. SC391317 | |||||||||
Biomorphis Limited Directors Report Registrar |
The Director presents his report and the accounts for the year ended 31 January 2024. | |||||||||
Principal activities | |||||||||
Director | |||||||||
The Director who served at any time during the year was as follows: | |||||||||
P.G. Forissier | |||||||||
Signed on behalf of the board | |||||||||
P.G. Forissier | |||||||||
Director | |||||||||
12 September 2024 |
Biomorphis Limited Balance Sheet Registrar |
at | ||||||||||
Company No. | Notes | 2024 | 2023 | |||||||
£ | £ | |||||||||
Fixed assets | ||||||||||
Tangible assets | 4 | |||||||||
Current assets | ||||||||||
Cash at bank and in hand | ||||||||||
Creditors: Amount falling due within one year | 5 | ( | ( | |||||||
Net current liabilities | ( | ( | ||||||||
Total assets less current liabilities | ( | ( | ||||||||
Net liabilities | ( | ( | ||||||||
Capital and reserves | ||||||||||
Called up share capital | ||||||||||
Profit and loss account | 6 | ( | ( | |||||||
Total equity | ( | ( | ||||||||
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account. | ||||||||||
Approved by the board on 12 September 2024 and signed on its behalf by: | ||||||||||
P.G. Forissier | ||||||||||
Director | ||||||||||
12 September 2024 |
Biomorphis Limited Notes to the Accounts Registrar |
for the year ended 31 January 2024 | ||||||||||||||
1 | General information | |||||||||||||
Biomorphis Limited is a private company limited by shares and incorporated in Scotland. | ||||||||||||||
Its registered number is: SC391317 | ||||||||||||||
Its registered office is: | ||||||||||||||
2 | Accounting policies | |||||||||||||
Turnover | ||||||||||||||
Revenue from the sale of goods is recognised when all the following conditions are satisfied: • the Company has transferred to the buyer the significant risks and rewards of ownership of the goods; • the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold; • the amount of revenue can be measured reliably; • it is probable that the economic benefits associated with the transaction will flow to the Company; and • the costs incurred or to be incurred in respect of the transaction can be measured reliably. Specifically, revenue from the sale of goods is recognised when goods are delivered and legal title is passed. | ||||||||||||||
Tangible fixed assets and depreciation | ||||||||||||||
At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss. | ||||||||||||||
Plant and machinery | ||||||||||||||
Trade and other creditors | ||||||||||||||
Foreign currencies | ||||||||||||||
3 | Employees | |||||||||||||
2024 | 2023 | |||||||||||||
Number | Number | |||||||||||||
The average monthly number of employees (including directors) during the year was: | ||||||||||||||
4 | Tangible fixed assets | |||||||||||||
Plant and machinery | Total | |||||||||||||
£ | £ | |||||||||||||
Cost or revaluation | ||||||||||||||
At 1 February 2023 | ||||||||||||||
At 31 January 2024 | ||||||||||||||
Depreciation | ||||||||||||||
At 1 February 2023 | ||||||||||||||
Charge for the year | ||||||||||||||
At 31 January 2024 | ||||||||||||||
Net book values | ||||||||||||||
At 31 January 2024 | ||||||||||||||
At 31 January 2023 | 4,745 | |||||||||||||
5 | Creditors: | |||||||||||||
amounts falling due within one year | ||||||||||||||
2024 | 2023 | |||||||||||||
£ | £ | |||||||||||||
Trade creditors | ||||||||||||||
Loans from directors | ||||||||||||||
Accruals and deferred income | ||||||||||||||
6 | Reserves | |||||||||||||